Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like Innovus Pharma Announces The Launch Of Zestra In France, Belgium And Monaco By Its Partner, September 18, 2017 Is There A Silver Lining For Fitbit? February 14, 2017 Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis October 2, 2017
Innovus Pharma Announces The Launch Of Zestra In France, Belgium And Monaco By Its Partner, September 18, 2017
Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis October 2, 2017
